CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Anthem Biosciences Ltd.

NSE : ANTHEMEQ BSE : 544449 ISIN CODE : INE0CZ201020Industry : Pharmaceuticals

News

  • Anthem Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 16 Jan 2026 | 16:20 | Dion Global

    As of December 2025 74.69% is owned by Indian Promoters and 25.31% by Public. Institutional holds 8.97% (Insurance Companies 0.44%) and Non-Instituti...more...

  • Anthem Biosciences - Compliance Certificate Under Regulation 74(5) Of SEBI (DP) Regulations, 2018 07 Jan 2026 | 16:27 | Dion Global

    Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018more...

  • Anthem Biosciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018 07 Jan 2026 | 16:19 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Anthem Biosciences - Giving guarantees/indemnity/ becoming a surety for third party 07 Jan 2026 | 14:23 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Giving guarantees/indemnity/ becoming a surety for third partymore...

  • Anthem Biosciences - Intimation Under Regulation 30 Of SEBI LODR Regulations With Reference To Issuance Of Corporate Guarante 07 Jan 2026 | 14:18 | Dion Global

    Issuance of Corporate Guarantee in favor of Citi Bank N.A and Federal Bank Limited amounting to Rs. 25 Crores and 24 Crores Respectively on behalf of...more...

  • Anthem Biosciences - Trading Window 29 Dec 2025 | 16:32 | Dion Global

    Anthem Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) ...more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15 Dec 2025 | 15:07 | Dion Global

    Intimation for Schedule of Analyst/Investor Meetmore...

  • Anthem Biosciences Q2 net profit up 16.52% at Rs 198.43 cr 18 Nov 2025 | 09:40 | Dion Global

    The company reported standalone net profit of Rs 198.43 crore for the quarter ended September 30 2025 as compared to Rs 170.30 crore in the ...more...

  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates 12 Nov 2025 | 18:23 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Transcriptmore...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 12 Nov 2025 | 18:19 | Dion Global

    Earnings Call Transcript for the financial result of quarter and half year ended September 30 2025more...

  • Anthem Biosciences - Intimation Of Violation Under Company'S Code Of Conduct To Regulate, Monitor And Report Trading By Desig 11 Nov 2025 | 12:21 | Dion Global

    Intimation of Action Taken report for violation of Company s Code of Conduct on Insider Trading Regulation.more...

  • Anthem Biosciences - Updates 11 Nov 2025 | 12:15 | Dion Global

    Anthem Biosciences Limited has informed the Exchange regarding Intimation of violation under Company s Code of Conduct to Regulate Monitor a...more...

  • Anthem Biosciences - Copy of Newspaper Publication 10 Nov 2025 | 17:16 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication of Financial results for the quarter and half year ended Sep...more...

  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates 10 Nov 2025 | 16:53 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Link of Recordingmore...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 10 Nov 2025 | 16:48 | Dion Global

    Audio recordings of Earnings Call for the quarter and half year ended September 30 2025more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release 08 Nov 2025 | 21:03 | Dion Global

    Press release for the financial result for quarter and half year ended September 30 2025more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Investor Presentation 08 Nov 2025 | 21:02 | Dion Global

    Investors Presentation for the financial results for quarter and half year ended September 30 2025.more...

  • Anthem Biosciences - Press Release 08 Nov 2025 | 20:59 | Dion Global

    Anthem Biosciences Limited has informed the Exchange regarding a press release dated November 08 2025 titled Financial result for quarter an...more...

  • Anthem Biosciences - Investor Presentation 08 Nov 2025 | 20:55 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Investor Presentationmore...

  • Anthem Biosciences - Outcome of Board Meeting 08 Nov 2025 | 20:11 | Dion Global

    Anthem Biosciences Limited has submitted to the Exchange the financial results for the quarter and half year ended September 30 2025.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex81537.7-0.94%
NSE Index25048.65-0.95%
BSE 1000 10539.53-1.37%
BSE 100LCTMC9236.63-1.13%
BSE Auto 59556.59-1.13%
BSE BasicMat7975.53-1.09%

Commodity

Gold136103-0.08%
Silver2462901.83%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 91.62(0.04 %)
GBP/INR 123.62(0.54 %)
EUR/INR 107.62(0.52 %)
JPY/INR 0.58(0.57 %)
CAD/INR 66.13(-0.46 %)
HKD/INR 11.74(-0.04 %)